Ocular surface disease associated with immune checkpoint inhibitor therapy
Author:
Funder
National Eye Institute
Research to Prevent Blindness
National Institutes of Health
Publisher
Elsevier BV
Subject
Ophthalmology
Reference63 articles.
1. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline;Brahmer;J Clin Oncol,2018
2. Immune checkpoint inhibitors: an innovation in immunotherapy for the treatment and management of patients with cancer;Dine;Asia-Pac J Oncol Nurs,2017
3. Clinical impact of checkpoint inhibitors as novel cancer therapies;Shih;Drugs,2014
4. Review of cancer treatment with immune checkpoint inhibitors: current concepts, expectations, limitations and pitfalls;Thallinger;Wien Klin Wochenschr,2018
5. Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma;Lipson;Clin Canc Res,2011
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ophthalmic Immune-Related Adverse Events and Association with Survival: Results from a Real-World Database;American Journal of Ophthalmology;2024-09
2. Adverse effects of anti-cancer biologics on the ocular surface;Current Opinion in Allergy & Clinical Immunology;2024-07-04
3. Impact of immune checkpoint inhibitors on vision and eye health;Eye;2024-07-03
4. Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management;Expert Review of Clinical Immunology;2024-06-25
5. Immune Checkpoint Inhibitor-induced Sicca Syndrome;Rheumatic Disease Clinics of North America;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3